TFEB and Alzheimer disease: Since compound C1 also can activate mTORC1 (Song et al., 2016; Figure S1J) and AKT (Figure S5), the pro‐survival signaling triggered by TFEB activation may also contribute to the neuroprotective effects of C1 in AD models.